CARDIOGENIC SHOCK: PAST, PRESENT, AND FUTURE CLINICAL TRIALS

Sunday, March 9, 2025

11:22 AM – 12:20 PM ET

Moderator(s)

Maya Guglin, MD

Director of Heart Failure/Transplant/MCS
Indiana University
Indianapolis, Indiana, United States

Disclosure information not submitted.
Srihari S. Naidu, MD, FSCAI

Director, Cath Labs and HCM Program
Westchester Medical Center
Valhalla, New York, United States

Disclosure(s): No financial relationships to disclose
Alexander G. Truesdell, MD

Interventional Cardiology
Virginia Heart / Inova Schar Heart and Vascular Institute
McLean, Virginia, United States

Disclosure(s): Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Getinge: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Srihari S. Naidu, MD, FSCAI: No financial relationships to disclose

Alexander G. Truesdell, MD: Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Getinge: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)